BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16493620)

  • 1. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
    Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
    Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin-mediated autoimmune thrombocytopenia.
    Saif MW; The A; Ledbetter L
    Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis.
    Sørbye H; Bruserud Y; Dahl O
    Acta Oncol; 2001; 40(7):882-3. PubMed ID: 11859992
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
    Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
    Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent priapism related to oxaliplatin infusion.
    Adenis A; Mailliez A; Rigot JM; Gamelin L; Vanhuyse M; Gamelin E
    J Clin Oncol; 2008 Feb; 26(6):1016-7. PubMed ID: 18281680
    [No Abstract]   [Full Text] [Related]  

  • 6. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
    Twelves C
    Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
    Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
    Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin-related acute disseminated intravascular coagulation syndrome in a patient with metastatic colon cancer.
    Malkhasyan K; Halene S; Lacy J
    Clin Colorectal Cancer; 2015 Mar; 14(1):e9-e12. PubMed ID: 25446051
    [No Abstract]   [Full Text] [Related]  

  • 11. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
    Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
    Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pain associated with oxaliplatin infusion: case report and literature review.
    Clay TD; Ashley DA
    J Oncol Pharm Pract; 2012 Dec; 18(4):421-4. PubMed ID: 22080592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
    Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
    Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
    Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
    Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
    [No Abstract]   [Full Text] [Related]  

  • 15. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.
    Wang J; Chang J; Yu H; Wu X; Wang H; Li W; Ji D; Peng W
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):905-11. PubMed ID: 23370661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic thrombocytopenic purpura during chemotherapy for liver metastasis of rectal cancer].
    Murata K; Mikami K; Yamada M; Ide Y; Owada Y; Nishigaki T; Nagase H; Mukai R; Momozane T; Murakami M; Okada K; Yanagisawa T; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2605-7. PubMed ID: 21224653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.